Jones, Jermaine D.
Funding for this research was provided by:
National Institute on Drug Abuse (R21DA043199, R21DA040225)
Article History
First Online: 4 April 2020
Compliance with Ethical Standards
:
: Financial support for the preparation of this article was provided by the National Institute on Drug Abuse (Baltimore, MD, USA) Grants R21DA043199 and R21DA040225 to Jermaine D. Jones.
: Over the past 3 years, Jermaine D. Jones has received partial salary support for a clinical trial partly funded by Cerecor Inc. Jermaine D. Jones is also the recipient of an investigator-initiated grant from Merck Pharmaceuticals studying human immunodeficiency virus among methamphetamine users.